Effects of postmenopausal hormone replacement therapy on lipoproteins including lipoprotein(a) and LDL subfractions

This publication has 30 references indexed in Scilit:

• Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS)
  European Journal of Clinical Investigation, 1994
• Epidemiology of triglycerides, small dense low-density lipoprotein, and lipoprotein(a) as risk factors for coronary heart disease
  Medical Clinics of North America, 1994
• Lipoprotein(a) and postmenopausal oestrogen
  Acta Endocrinologica, 1993
• The lowering of lipoprotein[a] induced by estrogen plus progesterone replacement therapy in postmenopausal women
  Archives of internal medicine (1960), 1993
• Association of Hormone-Replacement Therapy with Various Cardiovascular Risk Factors in Postmenopausal Women
  New England Journal of Medicine, 1993
• Lipoprotein (a) concentrations in postmenopausal women taking norethisterone.
  BMJ, 1991
• Low-density lipoprotein subclasses and risk of coronary artery disease
  Current Opinion in Lipidology, 1991
• Estrogen and coronary heart disease in women
  Published by American Medical Association (AMA) ,1991
• Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence
  Preventive Medicine, 1991
• The effects of conjugated equine oestrogens with and without a cyclical progestogen on lipoproteins, and HDL subfractions in postmenopausal women
  Acta Endocrinologica, 1986